During the last session, Artelo Biosciences Inc (NASDAQ:ARTL)’s traded shares were 1.08 million, with the beta value of the company hitting 1.36. At the end of the trading day, the stock’s price was $21.6, reflecting an intraday gain of 35.85% or $5.7. The 52-week high for the ARTL share is $25.58, that puts it down -18.43 from that peak though still a striking 77.22% gain since the share price plummeted to a 52-week low of $4.92. The company’s market capitalization is $14.77M, and the average intraday trading volume over the past 10 days was 3.7 million shares, and the average trade volume was 661.67K shares over the past three months.
Artelo Biosciences Inc (ARTL) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ARTL has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.78.
Artelo Biosciences Inc (NASDAQ:ARTL) trade information
Artelo Biosciences Inc (ARTL) registered a 35.85% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 35.85% in intraday trading to $21.6, hitting a weekly high. The stock’s 5-day price performance is 127.37%, and it has moved by 221.43% in 30 days. Based on these gigs, the overall price performance for the year is 239.62%. The short interest in Artelo Biosciences Inc (NASDAQ:ARTL) is 11794.0 shares and it means that shorts have 1.0 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 27.29%. While earnings are projected to return -218.03% in 2025, the next five years will return 28.82% per annum.
ARTL Dividends
Artelo Biosciences Inc is due to release its next quarterly earnings on 2025-May-13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Artelo Biosciences Inc (NASDAQ:ARTL)’s Major holders
Artelo Biosciences Inc insiders own 0.81% of total outstanding shares while institutional holders control 2.64%, with the float percentage being 2.66%.
Also, the Mutual Funds coming in first place with the largest holdings of Artelo Biosciences Inc (ARTL) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . Data provided on May 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 3.2 shares. This amounts to just over 0.59 percent of the company’s overall shares, with a $69141.0 market value. The same data shows that the other fund manager holds slightly less at 698.0, or about 0.13% of the stock, which is worth about $15076.0.
